Xarelto lawsuits continue to mount in the federal litigation now underway in the U.S. District Court, Eastern District of Louisiana. A case list recently issued by the U.S. Judicial Panel on Multidistrict Litigation indicates that, more than 1,230 claims had been filed proceeding as of August 15th.

That represents a significant increase since June, when the Panel had reported that fewer than 600 cases had been filed. According to Reuters, the Xarelto proceeding is now the fastest-growing multidistrict litigation currently underway in federal court.

Xarelto Bellwether Trials

Xarelto is a new-generation anticoagulant that was approved by the U.S. Food & Drug Administration in 2011. The drug’s label includes a black box warning that contains information about the increased risk of blood clot formation after premature discontinuation of the medication in the absence of adequate alternative anticoagulation. While the medication was intended as an alternative to warfarin, there currently exists no antidote to reverse Xarelto bleeding. By contrast, bleeding that sometimes accompanies the use of the older medication can be stopped via the administration of vitamin K.

The growth of the Xarelto litigation has been aided by a recent court decision allowing Xarelto lawyers to file “bundled complaints” that name multiple claimants. Earlier this month, four such complaints were filed in a single day on behalf of 189 plaintiffs, all of whom are alleged to have suffered severe bleeding complications due to Xarelto including gastrointestinal bleeding, hematuria, subdural hematoma, and cerebral hemorrhaging. The complaints also included a number of wrongful death claims. The four cases each involved as few as 11 and as many as 89 plaintiffs.

The federal proceeding was established in December 2014 to allow all federally-filed Xarelto cases to undergo coordinated pretrial proceedings, including discovery and motions practices. Eventually, four lawsuits will be chosen for bellwether trials, which could provide some clues as to jury decision in similar cases. Any Xarelto lawsuits that aren’t resolved through the multidistrict litigation process will be returned to its original court of filing for trial.

Bellwether trials in the Xarelto litigation are expected to get underway next August. The Court has proposed a trial plan that would allow the first to be convened on August 1, 2016, followed by a second trial on August 22, 2016, a third trial on September 12, 2016, and a fourth on October 17, 2016. The first two trials would be held in the Eastern District of Louisiana, while the third would take place in the Southern District of Texas, and the fourth in the Southern District of Mississippi. The four bellwether cases would be chosen from a discovery pool that will include 50 Xarelto lawsuits.

Xarelto Legal Reviews

Bernstein Liebhard LLP continues to offer free legal reviews to alleged victims of Xarelto bleeding side effects. To learn more, please call 1-877-779-1414.

Published August 26, 2015 by